A.M. Peny

566 total citations
12 papers, 406 citations indexed

About

A.M. Peny is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, A.M. Peny has authored 12 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Hematology. Recurrent topics in A.M. Peny's work include Multiple Myeloma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). A.M. Peny is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). A.M. Peny collaborates with scholars based in France, Switzerland and Belgium. A.M. Peny's co-authors include B. Grosbois, Christian Berthou, Jean‐Luc Harousseau, F. Huguet, Thierry Façon, A. Azzedine, Bruno Anglaret, Philippe Rodon, J.-Y. Génot and M Leporrier and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and British Journal of Haematology.

In The Last Decade

A.M. Peny

12 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.M. Peny France	9	257	120	96	87	85	12	406
J.D. Critchlow United Kingdom	10	266 1.0×	129 1.1×	196 2.0×	73 0.8×	55 0.6×	14	843
C.A. Uyl-de Groot Netherlands	12	258 1.0×	118 1.0×	54 0.6×	54 0.6×	116 1.4×	28	553
Helen Farrugia Australia	15	264 1.0×	45 0.4×	58 0.6×	94 1.1×	51 0.6×	25	530
Stephen S. Grubbs United States	10	354 1.4×	110 0.9×	71 0.7×	110 1.3×	40 0.5×	30	538
Jairam Krishnamurthy United States	12	236 0.9×	79 0.7×	90 0.9×	119 1.4×	41 0.5×	37	423
C Skosey United States	7	241 0.9×	206 1.7×	209 2.2×	236 2.7×	55 0.6×	7	623
Byung-Kiu Park South Korea	13	121 0.5×	86 0.7×	118 1.2×	81 0.9×	44 0.5×	27	495
Derek Cruickshank United Kingdom	16	229 0.9×	50 0.4×	48 0.5×	53 0.6×	99 1.2×	37	888
Sadashivudu Gundeti India	11	109 0.4×	131 1.1×	67 0.7×	91 1.0×	51 0.6×	69	381
Katiuscia O’Brian United States	8	139 0.5×	116 1.0×	98 1.0×	40 0.5×	76 0.9×	13	380

Countries citing papers authored by A.M. Peny

Since Specialization

Citations

This map shows the geographic impact of A.M. Peny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Peny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Peny more than expected).

Fields of papers citing papers by A.M. Peny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Peny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Peny. The network helps show where A.M. Peny may publish in the future.

Co-authorship network of co-authors of A.M. Peny

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Peny. A scholar is included among the top collaborators of A.M. Peny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Peny. A.M. Peny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Façon, Thierry, Jean‐Luc Harousseau, F. Huguet, et al.. (2006). Superiority of melphalan-prednisone (MP) + thalidomide (THAL) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma. Journal of Clinical Oncology. 24(18_suppl). 1–1. 148 indexed citations

2.

Piperno‐Neumann, Sophie, B. Bui, Jean‐Yves Blay, et al.. (2006). A multicentric prospective study of intensive induction chemotherapy (API-AI) in localized osteosarcoma patients: Results of a phase II trial coordinated by the French Sarcoma Group (FSG) and the FNCLCC BECT. Journal of Clinical Oncology. 24(18_suppl). 9521–9521. 9 indexed citations

3.

Fruchart, Christophe, Yves Denoux, Jacques Chasle, et al.. (2005). High Grade Primary Breast Lymphoma: is it a Different Clinical Entity?. Breast Cancer Research and Treatment. 93(3). 191–198. 20 indexed citations

4.

Brice, Pauline, Georges Fillet, A.M. Peny, et al.. (2001). Factors affecting hematopoietic recovery after autologous peripheral blood progenitor-cell transplantation in aggressive non-Hodgkin's lymphoma: a prospective study of 123 patients. The Hematology Journal. 2(2). 81–86. 3 indexed citations

5.

Brice, Pauline, Georges Fillet, A.M. Peny, et al.. (2001). Factors affecting hematopoietic recovery after autologous peripheral blood progenitor-cell transplantation in aggressive non-Hodgkin's lymphoma: a prospective study of 123 patients.. PubMed. 2(2). 81–6. 5 indexed citations

6.

Joly, Florence, M. Henry‐Amar, Patrick Arveux, et al.. (1996). Late psychosocial sequelae in Hodgkin's disease survivors: a French population-based case-control study.. Journal of Clinical Oncology. 14(9). 2444–2453. 98 indexed citations

7.

Gisselbrecht, Christian, J.M. Extra, Yves Devaux, et al.. (1996). Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.. PubMed. 18(5). 857–63. 24 indexed citations

8.

Bui, B., B Chevallier, Christine Chevreau, et al.. (1995). Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.. Journal of Clinical Oncology. 13(10). 2629–2636. 57 indexed citations

9.

Troussard, Xavier, Margaret Macro, A.M. Peny, et al.. (1995). Human recombinant granulocyte‐macrophage colony stimulating factor (hrGM‐CSF) improves double hemibody irradiation (DHBI) tolerance in patients with stage III multiple myeloma: A pilot study. British Journal of Haematology. 89(1). 191–195. 9 indexed citations

10.

Chevallier, B, N.B. Bui, F. Bonichon, et al.. (1993). Efficacy of lenograstim on hematological tolerance to maid chemotherapy in sarcoma patients and impact on dose intensity. European Journal of Cancer. 29. S186–S186. 1 indexed citations

11.

Monconduit, M, Jean-François Ménard, J. L. Michaux, et al.. (1992). VAD or VMBCP in severe multiple myeloma. British Journal of Haematology. 80(2). 199–204. 16 indexed citations

12.

Gramont, Aimery de, B. Grosbois, Jl. Michaux, et al.. (1990). Myélome à IgM: 6 observations et revue de la littérature. La Revue de Médecine Interne. 11(1). 13–18. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact